← brief for 2026-10-18 · Slowing decline
Cisplatin-associated hyponatremia: an outcome-definition and denominator problem
Key takeaways
This paper discusses how doctors define and count low sodium levels caused by a cancer drug. It is a discussion piece, so it does not report new clinical trial results.
Who did this work
Meryem Keleş (Sağlık Bilimleri Üniversitesi) · Emre Çankaya (Sağlık Bilimleri Üniversitesi)
Source
Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-17
https://doi.org/10.1007/s10157-026-02968-w